Streetbeat News

Revenues

HCI

HCI Group (NYSE:HCI) received varied analyst ratings, with a positive shift in the 12-month price target to $121.5, up 19.12% from $102. The company, engaged in property and casualty insurance, showed strong financial performance with a revenue growth of 40.31% and high profitability metrics. Analysts from Compass Point, Truist Securities, and JMP Securities raised their price targets, reflecting optimism about HCI's market standing and financial health.

Portfolio Pulse from Benzinga Insights

March 13, 2024 | 3:01 pm

ELF

e.l.f. Beauty (NYSE:ELF) has received diverse analyst ratings over the last three months, with a recent shift towards a more bullish outlook. The average 12-month price target has been raised to $195.36, indicating a 22.1% increase from the previous target. Analysts from firms like TD Cowen, DA Davidson, and B of A Securities have adjusted their ratings and price targets, reflecting changes in market dynamics and company performance. e.l.f. Beauty's financial performance shows strong market presence, revenue growth, profitability, and financial health, with significant achievements in market capitalization, net margin, ROE, ROA, and a conservative debt management approach.

Portfolio Pulse from Benzinga Insights

March 13, 2024 | 3:01 pm

TPX

Five analysts have recently updated their ratings on Tempur Sealy Intl (NYSE:TPX), showing a generally positive outlook with upgrades in price targets and ratings. The average 12-month price target is now $60.2, reflecting a 20.4% increase from the previous $50.00. The company's financials indicate a strong market presence but a slight decline in revenue growth. However, its net margin, ROE, and ROA surpass industry standards, despite a high debt-to-equity ratio.

Portfolio Pulse from Benzinga Insights

March 13, 2024 | 3:00 pm

PRPL

Purple Innovation (NASDAQ:PRPL) has been analyzed by 5 analysts over the past three months, showing a mix of bullish to indifferent sentiments. The average 12-month price target is $2.5, with a recent increase from $2.31. Analysts' actions include raising and lowering ratings and price targets, reflecting their adaptation to market conditions and company performance. Purple Innovation's financials indicate challenges in revenue growth, profitability, and asset utilization, with a revenue decline of -2.01% and a net margin of -25.72%.

Portfolio Pulse from Benzinga Insights

March 13, 2024 | 3:00 pm

OKE

Analysts have recently updated their ratings and price targets for ONEOK (NYSE:OKE), showing a mix of bullish to bearish sentiments. The average 12-month price target has been raised to $80.25, indicating a 6.59% increase from the previous target. Analysts from firms like JP Morgan, Barclays, and Citigroup have raised their price targets, reflecting optimism about ONEOK's performance. The company has shown solid revenue growth of 4.03% as of December 31, 2023, but faces challenges with below-industry benchmarks in net margin, ROE, and ROA.

Portfolio Pulse from Benzinga Insights

March 13, 2024 | 3:00 pm

NBIX

Neurocrine Biosciences (NASDAQ:NBIX) has been evaluated by 8 analysts over the past three months, showing a mix of bullish to bearish sentiments. The average 12-month price target is $151.88, marking a 7.72% increase from the previous target. Analysts from firms like Oppenheimer and JP Morgan have adjusted their ratings and price targets, reflecting changes in market conditions and company performance. Neurocrine Biosciences, a pharmaceutical company, has shown a 25.05% revenue growth rate as of December 31, 2023, but faces challenges in profitability and efficiency metrics.

Portfolio Pulse from Benzinga Insights

March 13, 2024 | 2:04 pm

ATEC

Alphatec Holdings (NASDAQ:ATEC) has received varying analyst ratings over the last quarter, with a recent shift towards bullish sentiment. The average 12-month price target has been raised to $19.00, indicating a potential upside. The company, specializing in spinal surgery technology, has shown significant revenue growth but struggles with profitability and high debt levels. Analysts' ratings and price target adjustments reflect changing market conditions and company performance.

Portfolio Pulse from Benzinga Insights

March 13, 2024 | 2:04 pm

DTE

DTE Energy (NYSE:DTE) has been analyzed by 5 analysts in the last three months, showing a mix of sentiments. The average 12-month price target is $114.2, up from $112.50, with recent ratings adjustments from firms like JP Morgan and Barclays. DTE Energy, a major utility provider in Michigan, faces a -24.17% revenue decline and below-average net margin, despite a strong ROE and ROA. Analysts' ratings and price targets reflect their views on the company's performance and market conditions.

Portfolio Pulse from Benzinga Insights

March 13, 2024 | 2:00 pm

MANH

Analyst ratings for Manhattan Associates (NASDAQ:MANH) show mixed sentiments, with recent updates indicating a positive outlook. The average 12-month price target is $242.0, reflecting an 11.39% increase from the previous target. Analysts from Citigroup, Rosenblatt, Raymond James, and Truist Securities have adjusted their ratings and price targets, suggesting optimism about the company's future performance. Manhattan Associates, a provider of supply chain and omnichannel software, has shown strong financial indicators such as a 20.27% revenue growth and impressive ROE and ROA, despite a below-average net margin.

Portfolio Pulse from Benzinga Insights

March 13, 2024 | 2:00 pm

ALGN

Align Tech (NASDAQ:ALGN) has received mixed analyst ratings over the past quarter, with a shift towards a more bullish outlook in the last 30 days. The average 12-month price target for ALGN has increased to $297.0, up from $255.50, indicating a positive sentiment shift. Analysts from firms like Piper Sandler and Goldman Sachs have adjusted their price targets and ratings, reflecting changes in market conditions and company performance. Align Technology, known for its Invisalign product, dominates the clear aligner market and has shown strong financial performance with significant revenue growth and profitability metrics.

Portfolio Pulse from Benzinga Insights

March 13, 2024 | 2:00 pm